Anrukinzumab - CISMeF

Preferred Label : Anrukinzumab;

NCIt synonyms : Immunoglobulin G1, anti-(human interleukin-13) Humanized Mouse Monoclonal Gamma 1 Heavy Chain 235L A, 238G A (221-218')-disulfide with Humanized Mouse Monoclonal Kappa Light Chain (227-227'':230-230'')-bisdisulfide Dimer;

NCIt definition : A humanized monoclonal antibody directed against interleukin-13 (IL-13) with anti-asthmatic and anti-inflammatory activities. Anrukinzumab binds to and blocks the activity of IL-13, which may result in the inhibition of IL-13-mediated inflammation. The IL-13 cytokine is an important mediator of allergic inflammation and other inflammatory processes.;

UNII : OU46IGC49F;

CAS number : 910649-32-0;

Molecule name : IMA-638;

Details

Origin ID

C95781;

UMLS CUI

C2987420;

Automatic exact mappings (from CISMeF team)
- anrukinzumab [MeSH concept]
Currated CISMeF NLP mapping
- anrukinzumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- anrukinzumab [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients